title: Severe acute interstitial pnuemonia and gefitinib.
authors.forename: Kate
authors.initials: K
authors.lastname: Sumpter
authors.forename: Catherine
authors.initials: C
authors.lastname: Harper-Wynne
authors.forename: Mary
authors.initials: M
authors.lastname: O'Brien
authors.forename: Jo
authors.initials: J
authors.lastname: Congleton
mesh_terms: D000208:Acute Disease; D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D000970:Antineoplastic Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D000077156:Gefitinib; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced* / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011799:Quinazolines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D011505:Protein-Tyrosine Kinases; D000077156:Gefitinib